Skip to content
★ Sign in to follow
PP
Total declarations
7
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€241k

Latest filing published 26 Mar 2021 for Myriad Genetics INC.

Filing timeline

BuySale
Paul Parkinson

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

Paul Parkinson: trading record in brief

All filings by Paul Parkinson on record concern Myriad Genetics Inc. We count 7 filings; the first trade dates from 25 September 2020 and the latest from 24 March 2021.

No open-market purchase appears, only 1 sale worth €241k. Other entries cover 2 share grants. So far in 2021, the count stands at no purchases and 1 sale.

The latest filing, published on 26 March 2021, reports a share grant in Myriad Genetics Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Paul Parkinson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ◆
    EVP Strategy and InnovationExecutivesMyriad Genetics Inc
    0SEC
    10,661 shares0Common StockSEC:0001826133-21-000004:0
  • ▼
    EVP Strategy and InnovationExecutivesMyriad Genetics Inc
    295,600 USD18SEC
    11,824 shares@ US$25.0074.4% of flowCommon StockSEC:0001826133-21-000002:0
  • ●
    EVP Strategy and InnovationExecutivesMyriad Genetics Inc
    27,570 USD14SEC
    2,218 shares@ US$12.4328.5% of flowCommon StockSEC:0001826133-20-000009:0
  • ◆
    EVP Strategy and InnovationExecutivesMyriad Genetics Inc
    0SEC
    21,730 shares0Common StockSEC:0001826133-20-000007:0
  • ●
    EVP Strategy and InnovationExecutivesMyriad Genetics Inc
    41,388 USD15SEC
    3,327 shares@ US$12.4442.9% of flowCommon StockSEC:0001826133-20-000005:2
  • ●
    EVP Strategy and InnovationExecutivesMyriad Genetics Inc
    27,592 USD14SEC
    2,218 shares@ US$12.4428.6% of flowCommon StockSEC:0001826133-20-000005:0

6 of 6 declarations